SNYR
Synergy CHC Corp.
NASDAQ · Healthcare · Medical - Distribution · US
$0.10
−4.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 27.7M | 30.4M | 34.8M | 42.8M | 38.4M |
| Cost of Revenue | 9.7M | 10.1M | 11.2M | 10.7M | 25.5M |
| Gross Profit | 18.0M | 20.3M | 23.6M | 32.1M | 13.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 22.3M | 22.0M | 17.7M | 21.2M | 37.9M |
| General & Admin Expense | 9.6M | 8.8M | 4.7M | 6.1M | — |
| Selling & Marketing Expense | 12.7M | 13.1M | 13.0M | 15.2M | — |
| Other Expenses | 66.7K | 133.3K | 133.3K | 33.3K | — |
| Total Operating Expenses | 22.4M | 22.1M | 17.8M | 21.3M | 37.9M |
| Cost and Expenses | 32.0M | 32.2M | 29.0M | 32.0M | 63.4M |
| Operating Income (EBIT) | (4.3M) | (1.8M) | 5.8M | 10.8M | (25.0M) |
| Non-Operating | |||||
| Interest Income | 719.00 | 15.1K | 1.5K | 1.6K | 569.00 |
| Interest Expense | 6.9M | 5.9M | 4.1M | 4.2M | 6.5M |
| Net Interest Income | (6.9M) | (5.9M) | (4.1M) | (4.2M) | (6.4M) |
| Other Non-Op Income/Expense | (11.4M) | (10.4M) | (3.6M) | (4.2M) | (7.6M) |
| Non-Operating Income (excl Interest) | 4.5M | 4.5M | (531.0K) | (3.1K) | 1.2M |
| EBT (Pre-Tax Income) | (15.7M) | (12.2M) | 2.2M | 6.6M | (32.6M) |
| Income Tax Expense | 115.2K | 117.5K | 102.1K | 235.0K | 32.2K |
| Bottom Line | |||||
| Net Income | (15.8M) | (12.3M) | 2.1M | 6.3M | (32.6M) |
| Earnings from Cont. Ops | (15.8M) | (12.3M) | 2.1M | 6.3M | (32.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (15.8M) | (12.3M) | 2.1M | 6.3M | (32.6M) |
| Per Share | |||||
| Basic EPS | ($1.60) | ($1.27) | $0.28 | $0.86 | ($0.36) |
| Diluted EPS | ($1.60) | ($1.27) | $0.28 | $0.07 | ($0.36) |
| Revenue Per Share | $2.45 | $3.12 | $4.59 | $5.80 | $0.43 |
| Shares | |||||
| Basic Shares Outstanding | 11.3M | 9.7M | 7.6M | 7.4M | 89.9M |
| Diluted Shares Outstanding | 11.3M | 9.7M | 7.6M | 89.9M | 89.9M |
| Profitability Metrics | |||||
| EBITDA | (8.7M) | (6.2M) | 6.5M | 10.8M | (25.8M) |
| D&A | 133.3K | 133.3K | 133.3K | 33.3K | 340.0K |
| EBIT | (8.8M) | (6.3M) | 6.3M | 10.8M | (26.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026